We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
summary
A letter providing guidance on the post-transition conversion process was sent by email on 23 October 2020 to the Community MA holders.
Information for manufacturers and users of medical devices containing plastic with DEHP phthalates.
Guidance on moving medicines by air
Information on the measures in the Health Service Medical Supplies (Costs) Bill.
Resources for pharmacies to achieve Healthy Living Pharmacy (HLP) Level 1 status.
How to use RamaXL, including system availability, running reports and how to subscribe.
To celebrate International Women’s Day 2023, some of our colleagues have shared their passion for STEM.
The Defence and Security Accelerator (DASA) is running a Market Exploration to explore the Non-Compressible Haemorrhage (NCH) environment. To understand who is doing work in this area and possible novel solutions of treatmen…
We can provide access to world-class regulatory knowledge, expertise and experience from within the MHRA.
Guidance on how to make reasonable adjustments to help support people with learning disabilities in using pharmacy services.
How to report adverse incidents involving cardiac ablation devices under the vigilance system.
How to report adverse incidents involving insulin infusion pumps and integrated meter systems under the vigilance system.
For manufacturers reporting adverse incidents with intraocular lenses under the vigilance system.
A unique initiative which aims to accelerate the time to patient care for transformative medicines and medicine-device combinations.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2022.
Update about the developing role of biosimilar medicines in the NHS in England and the safe, effective and consistent use of biosimilar medicines.
Guidance on labelling requirements pertinent to the type of medicinal product and its supply status, as defined in UK legislation.
From discovery to real-world impact, VDEC equips scientists with the expertise and facilities to navigate each step in the development of vaccines and therapeutics.
Applying for market authorisation for plasma master files (PMFs) and vaccine antigen master files (VAMFs).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).